<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo>, <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> with elements of both environmental and autoimmune pathologic processes </plain></SENT>
<SENT sid="1" pm="."><plain>Neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet, found in 10%-25% of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet patients, has been characterized as a <z:hpo ids='HP_0002633'>vasculitis</z:hpo> primarily affecting the brain stem </plain></SENT>
<SENT sid="2" pm="."><plain>On magnetic resonance imaging, some cases demonstrate extension to the bilateral cerebral cortices and/or the spinal cord, often with a degree of mass effect </plain></SENT>
<SENT sid="3" pm="."><plain>Content of this paper provides a case study, along with review of the literature regarding this disease entity, and proceeds to outline the appearance of neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet on magnetic resonance spectroscopy </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: In essence, a drop in the N-<z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="0" ids="29995">aspartate</z:chebi> peak indicative of <z:hpo ids='HP_0003447'>axonal loss</z:hpo> in concert with elevations in <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="0" ids="17268">myoinositol</z:chebi> and <z:chebi fb="3" ids="15354">choline</z:chebi>/<z:chebi fb="2" ids="16919">creatine</z:chebi> ratios (nonspecific markers of myelin breakdown) is found, indicating that a possible demyelinating process is complexed with the vasculitic pathology neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet is traditionally ascribed to </plain></SENT>
</text></document>